Aleutian Disease Virus

Overview, Taxonomy, and Virology of Aleutian Disease Virus

Overview

Aleutian mink disease virus (AMDV) is the etiologic agent responsible for Aleutian disease, a chronic and multisystemic infection that significantly impacts both farmed and free-ranging mink populations. The virus causes a persistent infection characterized by a hyperactive antibody response, leading to immune complex formation and progressive organ damage [1, 2]. Economically, AMDV is of critical importance, as its presence in mink farms worldwide has led to substantial losses in production and overall animal welfare concerns. Notably, the virus is recognized not only for its severe clinical manifestations among susceptible mink but also for its subclinical persistence, which complicates detection and control efforts [4, 10]. International bodies such as the CDC, OIE (WOAH), and FAO continuously emphasize the importance of strict biosecurity measures in managing pathogens like AMDV due to their potential for cross-species transmission and enduring environmental stability.

Taxonomy

From a taxonomic perspective, Aleutian mink disease virus is classified within the Parvoviridae family, specifically under the genus Amdoparvovirus. As a member of the Parvoviridae, AMDV is a small, non-enveloped virus with a single-stranded DNA genome. Unlike other parvoviruses that are known to cause acute cytopathic infections, AMDV demonstrates an unusual ability to establish persistent, subclinical infections that lead to chronic immune-mediated pathology [9]. Its genomic organization and virion structure share similarities with other parvoviruses; however, AMDV also exhibits unique molecular and antigenic properties that have warranted its separate classification. Insight into its taxonomy is crucial because the viral genetic markers, particularly those found in the NS1 and VP2 gene regions, not only guide classification but also serve as important targets for diagnostic assays and molecular epidemiological investigations [5, 16]. Phylogenetic studies have revealed that despite considerable genomic variation due to point mutations and recombination events, AMDV isolates often cluster according to their geographic origin and host history, underscoring both ancient and ongoing inter-farm transmission dynamics [11-13].

Virology

The virology of AMDV centers on its distinctive structure, replication strategy, and immune interactions. At the structural level, AMDV is built upon an icosahedral capsid composed of 60 copies of viral proteins, mainly VP2, which plays a central role in host receptor binding and eliciting immune responses. Recent cryo-electron microscopy studies have provided high-resolution images of the AMDV capsid, revealing significant structural variability, particularly in the surface loops that vary considerably even among closely related strains [9]. These surface loop variations are believed to influence receptor interactions and contribute to the virus’s ability to evade neutralizing antibodies, a vital aspect of its persistence within infected populations.

The single-stranded DNA genome of AMDV encodes both nonstructural and structural proteins. The NS1 protein is one of the most critical viral components, having multiple roles in viral replication, genome packaging, and modulation of host immune responses. Mutations within the NS1 region have been linked to differences in virulence among strains, and unique nucleotide changes have been documented in strains associated with acute outbreaks [6, 7]. In parallel, VP2, the major capsid protein, is highly immunogenic and is under constant selective pressure exerted by the host’s humoral immune response. This interaction forms the basis for many diagnostic tests, including ELISAs that quantify antibody titers, which in turn correlate with disease progression in chronically infected mink [8, 19].

AMDV’s replication mechanism is similar to other parvoviruses: after attachment to host cell receptors, the virus enters via receptor-mediated endocytosis and traffics to the nucleus, where host DNA polymerases replicate the viral genome. However, rather than inducing a rapid cytolytic response, AMDV’s replication is characterized by a slow but persistent process that promotes long-term viral shedding and chronic infection. This unusual replication strategy results in a sustained state of immune activation that is responsible for the characteristic hypergammaglobulinemia observed in infected mink [1, 8]. Additionally, the virus exhibits a pronounced tissue tropism for lymphoid organs such as the spleen and lymph nodes. Quantitative PCR studies have demonstrated that these tissues harbor higher viral loads compared to other organs, a finding that is central to understanding both the pathogenesis of the disease and the challenges involved in its diagnosis [10, 14].

High-throughput sequencing and whole-genome analyses have further enhanced our understanding of AMDV’s evolution. Such studies reveal that the virus undergoes frequent recombination and mutation events, contributing to its extensive genetic diversity [11, 17, 20]. This genetic plasticity not only complicates vaccine development but also underpins the virus’s capability to adapt to different host populations and environmental pressures. Molecular epidemiological investigations routinely employ partial and full-genome sequencing of the NS1 and VP2 regions to track transmission routes, elucidate outbreak sources, and evaluate inter-farm spread [16, 18]. Notably, these analyses have shown that strains from farmed and wild mink, despite sharing a common ancestral origin, often diverge into distinct lineages with specific molecular signatures that can be correlated with clinical outcomes and regional spread patterns.

The persistent nature of AMDV is further compounded by its stability in environmental reservoirs, a feature that heightens the risk of inadvertent transmission through contaminated fomites or vectors [3, 15]. Given that the virus’s non-enveloped structure allows it to remain infectious in diverse environmental conditions, stringent biosecurity protocols are imperative. This has been a cornerstone of recommendations issued by leading animal health organizations, which advocate for not only rigorous on-farm interventions but also continuous molecular surveillance to mitigate the economic and health impacts of AMDV in both farmed and wild populations [1, 21].

Molecular Pathogenesis and Host-Pathogen Interactions of Aleutian Disease Virus

Aleutian disease virus (ADV), classified within the Amdoparvovirus genus of the Parvoviridae family, exhibits a particularly complex molecular pathogenesis that intricately intertwines viral replication dynamics with host immune responses. ADV is characterized by its small, non-enveloped, single-stranded DNA genome that encodes both non-structural proteins (NS1-3) and structural proteins such as VP2, which contribute to its tolerance and pathogenicity within mink populations and other mustelids. Detailed studies have revealed that ADV possesses significant genetic heterogeneity and a capacity for recombination, ensuring persistent circulation in both wild and farmed populations [1, 6, 11].

Viral Structure and Genome Organization

The structural characterization of ADV, achieved through advanced techniques such as cryo-electron microscopy, has shed light on the intricate architecture of the capsid proteins. The capsid is arranged in a T = 1 icosahedral symmetry with 60 subunits which interact via loops and surface protrusions that are subject to high rates of amino acid variation [9]. These variable regions, particularly within the VP2 protein, not only determine the antigenic properties of the virus but also provide insight into how minor nucleotide changes can lead to altered host interactions and immune evasion mechanisms. The extensive variability in the hypervariable regions, as evidenced by the detection of unique nucleotide mutations and corresponding amino acid substitutions in specific strains [6], underscores the virus’s ability to modulate its phenotype and adapt to different host immune pressures.

Mechanisms of Viral Replication and Immune Evasion

At the heart of ADV’s molecular pathogenesis is its intricate replication cycle and capacity for immune evasion. Transcription of the viral genome, primarily mediated by the non-structural proteins such as NS1, initiates processes that are critical for viral DNA rearrangement and replication. Studies have identified point mutations in NS1-encoding regions (e.g., unique substitutions such as A374C and T476A resulting in amino acid changes) that may influence replication efficiency and pathogenicity [6]. These mutations, along with the observed genetic diversity across global isolates [11, 16], suggest that viral adaptation at the genomic level plays a crucial role in determining virulence and persistence.

ADV is notorious for establishing chronic infection through mechanisms that subvert the host’s innate and adaptive immune responses. The virus can replicate to establish a persistent viremia that gradually declines over time, while the antibody response, once mounted, continues to increase. Such a scenario creates a unique milieu in which immune complexes form, contributing to hypergammaglobulinemia and deposition within organs such as kidneys, liver, and lymphoid tissues [1, 10]. The formation of these circulating immune complexes is central to disease pathogenesis, as they induce inflammatory responses and tissue damage mediated by complement activation and recruitment of mononuclear cells. This immune complex-mediated pathology is considered a hallmark of ADV infection and is intimately linked with the chronic course of the disease.

Host Immune Responses and Immune Complex Formation

The interplay between ADV and the host immune system is paradoxical. On one hand, the production of antibodies is essential for viral neutralization; on the other, these same antibodies can contribute to the deposition of immune complexes that trigger pathological changes. The persistent antibody production observed in chronically infected mink leads to high levels of circulating immunoglobulins, particularly IgG, which, when bound to viral antigens, form complexes that may not be efficiently cleared. These deposits instigate local inflammation and are responsible for some of the multisystemic manifestations of Aleutian disease [1, 10].

Investigations have shown that the immune response, although robust in terms of antibody production, fails to clear the virus. Instead, it perpetuates a state of immune dysregulation where macrophages, plasma cells, and various lymphocyte subsets are continuously activated. In experimental paradigms where mink are inoculated via different routes (intranasal, intraperitoneal, and oral), variations in the timing and magnitude of viral DNA detection and antibody responses have been documented [26]. Notably, the chronic elevation of antibody titers, even in the face of declining viremia, suggests that immune stimulation persists due to either low-level viral replication in tissue sanctuaries or the continual presence of residual antigenic material. This state of persistent immune activation is a significant contributor to the pathogenesis of ADV, as it predisposes the host to immune complex-mediated tissue injury.

Genetic Factors and Host Resistance

Host-pathogen interactions in ADV infection are not solely defined by viral factors; host genetic predispositions also play a significant role. Recent genomic studies have identified candidate genes and specific polymorphisms that correlate with resistance or tolerance to ADV infection in mink. For example, polymorphisms within the RNF165 gene have been associated with differential susceptibility between farmed and wild mink, potentially influencing viral entry, innate immune signaling, or antigen processing [22]. In addition, genome-wide selection signatures have identified genomic regions enriched with immune-related genes such as TAP2, RAB32, and genes within the MHC class II complex that modulate the host's ability to mount a balanced immune response [23, 24].

These genetic determinants influence not only the magnitude of antibody titers but also the severity of inflammatory lesions observed in tissues. Mink that are genetically predisposed to a tolerant phenotype tend to exhibit relatively lower viral copy numbers, milder histopathological lesions, and reduced hypergammaglobulinemia [7, 10]. The interplay between these host factors and the structural variability of the virus thus defines the dynamic equilibrium observed in ADV infection, wherein the host does not fully clear the virus but is able to sustain relatively normal health and production traits in the face of persistent viral circulation.

Furthermore, the chronicity of ADV infection and its propensity to promote continuous immune complex formation may inadvertently provide selection pressure that drives viral evolution. The establishment of persistent infections in large mink populations, where genetic selection for tolerance is practiced, underscores the bidirectional nature of host-pathogen interactions. On one side, the virus adapts via subtle genetic shifts in key proteins such as VP2 and NS1, while on the other, mink populations are increasingly bred for traits that mitigate immune-mediated damage without necessarily reducing viral load [7, 24]. This evolutionary arms race presents both challenges and opportunities, understanding the molecular underpinnings of these interactions may eventually facilitate the development of targeted therapeutics or improved diagnostic assays, as highlighted by emerging approaches including aptamer-targeting strategies against ADV [25].

In the broader context of zoonotic and economically significant pathogens, agencies such as the CDC, WHO, and WOAH recognize that the comprehensive study of molecular pathogenesis and host-pathogen dynamics is critical. Such data not only inform disease management and biosecurity practices in affected animal industries but also enhance our preparedness for potential cross-species transmission events. Although ADV primarily impacts mink, the principles uncovered in its molecular interactions and immune evasion strategies are applicable to understanding similar mechanisms in other persistent viral infections encountered in veterinary and human health settings.

Epidemiology and Global Distribution in Mink Populations

Aleutian disease virus (AMDV) represents a pervasive pathogen that has inflected a significant toll on both farmed and free-ranging mink populations around the world. Observations across multiple continents corroborate its widespread distribution, which is inextricably linked to factors such as intensive farming practices, transcontinental animal trade, and the spillover into wild mustelid reservoirs. The virus exhibits a remarkable capacity for persistence and evolution, driven by its molecular variability, recombination events, and complex host–pathogen interactions.

Worldwide Distribution in Farmed Mink

Numerous investigations underscore that farmed mink populations are critical epicenters for AMDV circulation. In mink-producing countries, the virus is endemic, with infection rates that have been detected through both serological and molecular techniques. For instance, recent studies have revealed that the infection in farmed mink has virtually achieved a global footprint, with molecular analyses affirming the presence of distinct viral clades across various geographic regions [1, 15]. In intensive husbandry settings, AMDV is known not only to persist but also to evolve in situ, spurred on by factors such as high animal density, repeated animal introductions, and occasional lapses in biosecurity. Additionally, some farms that have attempted selective breeding for disease tolerance still document continued virus circulation, albeit with lower clinical impacts in tolerant mink populations [7, 24]. This suggests that while management strategies can reduce overt clinical presentations, they do not necessarily eliminate the viral reservoir within these operations.

A salient feature of AMDV epidemiology in farmed mink is the evidence of multiple introduction events into these communities, as reflected by the high degree of genetic variation found among isolates from the same country. Studies in Poland, for instance, have documented large genetic distances between isolates from different voivodeships, a finding consistent with repeated, independent introductions possibly via international trading networks [15]. Similarly, retrospective investigations in southwestern European farms have utilized phylogenetic analyses of NS1 and VP2 gene sequences to demonstrate that outbreak strains in Spain have clustered into several distinct clades, indicative of within-farm reservoirs as well as occasional introductions from abroad [13]. These observations are in line with recommendations from international institutions such as the World Organisation for Animal Health (WOAH) regarding the importance of heightened surveillance and biosecurity for economically critical pathogens.

Infection Dynamics in Free-Ranging and Feral Mink

While the concentrated populations on farms provide a fertile ground for the virus, free-ranging mink similarly play a pivotal role in the transmission cycles of AMDV. Outbreak tracking in regions such as northeastern Poland has revealed that free-ranging mink present a high prevalence of AMDV, with some studies documenting overall PCR positivity rates above 40% [4]. Notably, the genetic homogeneity among strains in free-ranging populations may reflect long-term establishment and adaptation in natural habitats, yet recent analyses also indicate the emergence of unique variants suggestive of ongoing genetic diversity [4, 28].

Additional research has focused on environmental factors, where spatial proximity to mink farms has been shown to heighten infection rates in wild populations. For example, studies from Iceland and Sweden have demonstrated that the prevalence of AMDV in feral mink correlates with proximity to farming zones, implying that farm escapees may act as vectors facilitating the transmission of the virus into the wild [29, 32]. This dynamic is further amplified by the potential for cross-species transmission among mustelids. The introduction of American mink to new regions has not only allowed AMDV to establish itself in these animals but has also resulted in spillover into native predators and meso-predators, as documented by seroprevalence studies in European badgers, polecats, and weasels [27, 28].

Molecular Diversity and Recombination

The evolutionary behavior of AMDV in mink populations is characterized by formidable genetic diversity and a propensity for recombination. Whole genome sequencing and partial gene analyses have revealed that viral strains circulate in both intensive farming systems and natural environments with considerable heterogeneity [11, 17]. In northern European countries such as Finland, the molecular epidemiology portrays a scenario of multiple introductions followed by frequent recombination events. Such recombination can facilitate the emergence of novel strains with altered virulence, adaptability, and transmission characteristics [11, 12].

Moreover, deep molecular comparisons between strains derived from farmed and wild mink hint at a divergence driven by distinct epidemiological niches. In farmed mink, genomic signatures often point to selection pressures favoring variants with improved tolerance or decreased pathogenicity, particularly in the context of long-term breeding programs [23, 24]. Conversely, in free-ranging populations, the virus exhibits a more unrestrained evolutionary trajectory, compounded by interspecimen variability and the potential for co-infection by multiple viral strains within a single host, phenomena that underscore the complexity of chronic AMDV infections [4, 11, 28].

Transmission Mechanisms and Environmental Considerations

Transmission of AMDV occurs via a combination of direct contact and environmental contamination. The high rate of viral shedding in infected mink, coupled with the virus’s robustness outside the host, facilitates its persistence on fomites, in bedding, and even on personal protective equipment used during farm visits [3, 31]. Such environmental reservoirs represent a major challenge for disease control, as the virus can be mechanically transmitted by insects, a fact underscored by recent reports implicating flies as potential vectors in mink farms [30].

The shared ecology between farmed and free-ranging mink underscores a complex, bidirectional transmission pathway where farm escapees may seed wild populations, and conversely, free-ranging mink may reintroduce novel variants into farms. This interplay further complicates efforts aimed at eradication or sustainable disease management, necessitating a holistic One Health approach that integrates veterinary authorities with agencies such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to develop coordinated response strategies [12].

Role of Host Genetics and Selection Measures

Host genetic factors greatly influence the epidemiological landscape of AMDV. Evidence exists for the presence of selection signatures in American mink that correlate with tolerance to AMDV infection. Mink selected over multiple generations for reduced antibody responses and enhanced tolerance display distinct genetic profiles that not only mitigate virus replication but also reduce the severity of lesions and clinical signs associated with the infection [2, 7, 24]. However, the persistence of subclinical infections in these populations implies that even tolerant mink may harbor and shed the virus, thereby contributing quietly to its global dissemination.

Studies leveraging high-throughput quantitative ELISA and PCR techniques have fine-tuned our ability to track both overt and subclinical infections, enabling more robust epidemiological models. These developments, combined with the integration of molecular epidemiology data, provide critical insights for devising biosecurity measures and inform policies at national and international levels, as recommended by agencies such as FAO for economically important pathogens affecting animal production [1, 8, 18].

Collectively, the epidemiological picture of AMDV in mink populations is multifaceted, featuring a complex interplay of transmission dynamics, viral evolution, and host factors that collectively facilitate its persistence and global distribution.

Advanced Molecular Diagnostic Techniques for AMDV

Advanced molecular diagnostic techniques have revolutionized the detection and characterization of Aleutian mink disease virus (AMDV), an economically critical pathogen for mink farms worldwide. Recent studies have underscored the importance of utilizing highly sensitive and specific assays, not only to confirm the presence of the virus in various biological samples but also to enable a detailed understanding of its genetic diversity and epidemiological dynamics [1, 3, 33]. Enhanced nucleic acid amplification methods, such as quantitative real-time PCR, have emerged as a gold standard assay in modern diagnostics. For instance, duplex PCR protocols targeting both the non-structural (NS1) and structural (VP2) regions have demonstrated amplification sensitivity down to as few as 10^2 copies per reaction, thereby expanding diagnostic capabilities to environmental samples and atypical tissues [3].

In addition, the development of probe-based and EvaGreen-based real-time PCR assays has provided robust platforms for detecting AMDV with high sensitivity. EvaGreen real-time PCR, for example, relies on melting temperature analysis and has been validated against conventional methods, revealing high reproducibility for both American and Chinese strains of AMDV [34]. These assays are particularly useful when rapid and universal detection is essential in outbreak situations. Their rapid turnaround time and high sensitivity are critical when integrated into surveillance programs endorsed by organizations such as the CDC and WOAH, ensuring that contaminated animal facilities are quickly identified and managed to prevent further spread.

Recent innovations include the use of whole-genome sequencing (WGS) that enables an exhaustive view of AMDV’s genomic architecture. By leveraging long-range PCR coupled with next generation sequencing platforms, researchers have captured entire viral genomes, revealing key genomic variations that may influence virulence and host adaptation mechanisms [17, 20]. The ability to conduct phylogenetic analyses at the whole-genome level has allowed for the intricate tracking of inter-farm transmission events and virus evolution, transforming raw sequence data into actionable epidemiological insights. Such integrative approaches are crucial for agencies like the WOAH and FAO, which emphasize comprehensive surveillance and traceability for zoonotic and economically impactful pathogens.

Serological Assays for Anti-AMDV Antibodies

Given the complex clinical manifestations of Aleutian disease, serological assays remain an essential diagnostic pillar, offering insights into host immune responses over the course of chronic infection. Traditionally, counter-immunoelectrophoresis (CIEP) has been employed as the gold standard for qualitative detection of anti-AMDV antibodies. However, modern trends have shifted towards enzyme-linked immunosorbent assays (ELISAs) that provide both qualitative and quantitative data on antibody levels, thereby allowing for detailed assessments of hypergammaglobulinemia, a hallmark response in AMDV infection [8, 19]. High-throughput quantitative ELISAs, particularly those based on the VP2 antigen, have been adapted to work with alternative sample types such as dried blood spot (DBS) specimens. This adaptation not only simplifies sample collection logistics but also maintains a strong correlation with conventional serological parameters such as the albumin:globulin ratio, further supporting its utility in both field and laboratory settings [8].

Moreover, comparative studies have demonstrated that recombinant antigen-based ELISAs yield reliable ranking of animal antibody titres, a critical parameter in breeding programs aimed at selection for disease tolerance [19]. The ability to discern between different levels of antibody response is integral in both diagnostic and genetic selection efforts, ensuring that animals with lower titers, which are often indicative of better clinical outcomes, can be identified and preferentially bred. This is particularly relevant as selection for tolerance to AMDV is emerging as a feasible strategy to mitigate the disease’s impact on mink health and productivity [2, 10, 36]. The integration of these assays into routine diagnostic workflows enables simultaneous testing for infection and determination of quantitative antibody responses, valuable in both outbreak management and long-term monitoring.

Emerging Diagnostic Innovations and Serological Applications

Beyond traditional PCR and ELISA methods, emerging diagnostic innovations are broadening the scope of AMDV detection. One promising strategy involves the use of aptamer-based therapeutics and diagnostic tools. Recent research into aptamer selection using magnetic beads-based SELEX has identified candidates that not only bind AMDV proteins with high specificity but also exhibit a sustained inhibitory effect on viral replication in vitro [25]. This dual functionality exemplifies how novel molecular tools can serve both as diagnostics and as potential therapeutics for viral pathogens that remain a persistent threat to animal health.

Another significant advancement is the application of direct PCR methods that bypass conventional nucleic acid extraction procedures. For example, the use of thermostable polymerases such as Omni Klentaq-LA has allowed for direct detection of viral DNA in blood and tissue homogenates, leading to faster turnaround times and reducing sample handling errors, a critical asset in settings where the virus persists at low copy numbers [35]. This method is particularly advantageous in chronic infections where the viral load may be minimal, and any loss during sample processing could lead to a false negative result.

Furthermore, integration of advanced molecular diagnostics with serological assays is proving instrumental in epidemiological investigations. Whole-genome sequencing, when coupled with detailed serological data, provides a comprehensive framework for mapping transmission pathways, both at the farm level and across wider geographic regions [17, 20]. Genomic data, in combination with antibody profiling, can reveal patterns of infection persisting in both farmed and wild mink populations and can assist public health authorities and agricultural bodies referenced by global entities (e.g., WHO, FAO) in refining control measures based on One Health principles.

Finally, technological improvements in assay platforms and sample processing, including the use of dried blood spot methodologies and point-of-care testing devices, underscore a trend towards diagnostics that are not only precise but also accessible in field conditions [8]. These methodological advancements empower rapid decision-making, which is critical in controlling outbreaks and in implementing biosecurity measures, as endorsed by international regulatory agencies.

Collectively, the interplay between advanced molecular diagnostics and serological assays has transformed our approach to managing Aleutian mink disease virus. The rigorous application of these technologies enables high-resolution detection, facilitates detailed epidemiological tracking, and guides genetic selection strategies for tolerance, essential components to mitigate the economic burden of this pathogen on the mink breeding industry.

Clinical Manifestations in Infected Mink

In minks infected with Aleutian Disease Virus (AMDV), the clinical picture is characteristically complex and multifaceted. The infection exhibits a multi‐systemic involvement that can vary considerably between age groups and even among genetically distinct animals within the same population. Adult mink often present with a subclinical course of the disease, while younger kits may exhibit more pronounced clinical signs, including respiratory distress and failure to thrive [1]. Despite the overt absence of clinical signs in many adult animals, infected mink consistently show evidence of poor health at the cellular and physiological levels. Hypergammaglobulinemia is a hallmark of AMDV infection, reflecting an aberrant and dysregulated humoral immune response. This excessive production of immunoglobulins, triggered by the persistent presence of viral antigens, correlates with immune complex formation and subsequent deposition in various tissues. These immune complexes contribute not only to tissue damage but also to the chronicity of the disease, even in the absence of overt symptoms [8, 14].

The variability of clinical manifestations is further compounded by differences in viral strain virulence, host genetics, and the overall immune status of the animal [2, 7]. In some outbreaks, sudden death has been observed in adult breeding mink, where detailed genomic analyses have revealed unique mutations associated with enhanced pathogenicity [6]. Other cases exhibit insidious progression, with histopathological lesions evident only upon detailed tissue examination. Organs commonly afflicted include the kidneys, liver, spleen, and lymphatic tissue, with lesions ranging from mononuclear cell infiltrations to more severe immune complex-mediated glomerulonephritis. The chronic infection is characterized by persistent viremia at low levels juxtaposed with consistently high antibody titers, suggesting an ineffective viral clearance mechanism despite an intense humoral response [1, 10, 38].

Immune Dysregulation and Its Biological Underpinnings

The immune dysregulation accompanying AMDV infection is a central feature that underscores the pathogenic complexity of the virus. One of the most critical aspects of this dysregulation is the disproportionate and sustained production of antibodies. Instead of mediating effective viral clearance, these antibodies form complexes with viral particles, eventually depositing in tissues and inciting a cascade of inflammatory responses. The resulting chronic inflammation manifests as plasmacytosis and hypergammaglobulinemia, conditions that compromise normal organ function [8, 14]. Molecular investigations have revealed that the host’s genetic background can have a considerable influence on the trajectory of the immune response. Specific gene polymorphisms, such as those identified in the RNF165 gene, have been implicated in modulating the host’s susceptibility to AMDV infection by affecting immune response pathways and virus–host interactions [22].

The interplay between viral replication and immune activation creates an environment where the host’s defense mechanisms are both overactive and ineffective. Studies employing high-throughput quantitative ELISAs have demonstrated that despite the high levels of specific antibodies, viral replication persists at low levels in various tissues, indicating a state of continual immune activation without resolution of infection [1, 10]. This paradox is further illustrated by investigations into follow-up antibody titers over extended periods; while antibodies remain elevated, they do not correlate with an efficient clearance of the virus, suggesting that these antibodies might be functionally inert or even directly pathogenic by forming deleterious immune complexes [8]. In addition to humoral responses, alterations in cell-mediated immunity have been observed, albeit less consistently documented. Such alterations may include the downregulation of specific cytokine responses and a skewing of the T-cell repertoire, ultimately leading to impaired control of viral dissemination within the host.

Elevated antibody titers have also been linked to secondary complications, including an increased susceptibility to opportunistic bacterial infections. This immunosuppression or, more accurately, the misdirection of the immune response, further compromises the overall health of the infected mink and contributes to the high incidence of mortality in affected herds [2]. The significance of these findings is not limited to mink farming; organizations such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) have underscored the economic and animal welfare implications of pathogens that dysregulate the immune system, particularly when chronic infections are difficult to control [1, 21].

Reproductive Impacts and Associated Economic Consequences

Reproductive failure is one of the most profound and economically important sequelae of AMDV infection in mink populations. Infected mink frequently exhibit marked reductions in fecundity as well as recurrent miscarriages. The clinical investigations have consistently shown that AMDV infection is associated with lower litter sizes at both birth and weaning [2, 37]. The presence of the virus in the reproductive tract, coupled with systemic immune complex deposition, can lead to suboptimal conditions for embryonic development and early postnatal survival. For example, chronically infected females may experience placental insufficiency accompanied by immune-mediated damage, which jeopardizes the viability of developing kits. These reproductive impairments have been directly correlated with the disease’s immunopathogenic mechanisms, highlighting the intricate connection between immune dysregulation and reproductive failure [2, 24].

Studies have described how chronic AMDV infection leads not only to direct viral damage but also to secondary complications that impair reproductive performance. For instance, persistent hypergammaglobulinemia and high serum antibody titers have been inversely correlated with key reproductive parameters, such as litter size and kit survival [2, 37]. Infected females often show signs of systemic illness that may include reduced weight gain and altered hormonal balance, factors which are critical determinants of reproductive success. Consequently, farms with endemic AMDV face the dual challenge of managing both the subclinical disease in adult mink and the overt reproductive losses that severely impact productivity [2, 37].

Furthermore, the chronic nature of the infection implies that economic losses are not solely limited to the reduced reproductive output but also include increased veterinary costs and management interventions aimed at mitigating secondary infections. Surveillance methods, including high-throughput quantitative ELISAs and PCR-based protocols, have been instrumental in monitoring disease progression; however, the persistence of subclinical infections continues to pose a significant challenge to effective disease control [8, 10]. In addition to these practical challenges, recent research on the genetic control of immune responses and reproduction in mink has opened avenues for genomic selection strategies that aim to breed individuals with improved tolerance to AMDV infection, thereby potentially mitigating some of the reproductive losses associated with the disease [1, 24].

Taken together, the interconnected facets of clinical manifestations, immune dysregulation, and reproductive dysfunction in AMDV-infected mink illuminate the multifactorial nature of the disease. The ongoing research efforts underscore the necessity for integrative management approaches that encompass molecular diagnostics, selective breeding, and robust biosecurity measures endorsed by global authorities such as the CDC, WHO, and FAO for economically critical pathogens. Consistent monitoring and deeper molecular investigations are essential to improving animal welfare and sustaining productive mink farming in regions impacted by AMDV.

Vaccine Response, Immune Suppression, and Secondary Infections in Chronic Cases

Chronic infection with Aleutian mink disease virus (AMDV) is recognized for its complex interplay between viral replication, host immune dysregulation, and altered vaccine responses. In chronically infected mink, persistent viral replication drives a state of immune overstimulation that is characterized by hypergammaglobulinemia, formation of immune complexes, and a paradoxical suppression of protective cellular responses. This immunological chaos not only hampers the host’s ability to mount effective responses to vaccines against other pathogens but also predisposes infected animals to secondary bacterial and opportunistic infections.

Vaccine Response in the Context of Chronic AMDV Infection

Studies have indicated that the mismatch between a vigorous yet non-protective humoral response and insufficient effective immunity plays a central role in the phenomenon of poor vaccine performance in AMDV-infected populations. For instance, when mink with subclinical AMDV infection were vaccinated against canine distemper, the specific humoral immunity elicited by the vaccine was significantly compromised due to the ongoing immune complex disease associated with AMDV [2]. The chronic presence of viral antigens leads to a state of immune exhaustion where high titers of non-neutralizing antibodies persist, thereby interfering with the generation of robust protective responses upon vaccination. This means that despite vaccination efforts, the background immune activation from AMDV can blunt both the magnitude and quality of the immune response required for optimum protection against other pathogens.

The inability of the immune system to generate an effective response is compounded by the chronic inflammatory milieu. Elevated systemic levels of immunoglobulins in response to AMDV infection reflect continuous antigenic stimulation, which diverts immune resources and reduces the capacity of antigen-presenting cells to process and present new vaccine antigens. This phenomenon is of concern, particularly in regions where robust vaccination programs are a critical component of disease control as recommended by institutions such as the CDC and WHO for related zoonotic pathogens and economically significant diseases. A compromised vaccine response in AMDV-affected mink has direct implications for disease control strategies in fur farming, where suboptimal immunity may facilitate the spread of both AMDV and other vaccine-preventable diseases [2, 7].

Mechanisms of Immune Suppression in Chronic AMDV Infection

At the molecular level, AMDV orchestrates immune suppression through several interlinked mechanisms. Chronic infection leads to persistent polyclonal B-cell stimulation, which results in an abnormal expansion of plasma cells and an increase in overall antibody production. However, these antibodies are often of low specificity and affinity, forming circulating immune complexes that deposit in organs such as the kidneys, liver, and spleen. The subsequent tissue damage and chronic inflammation further disrupt normal immune surveillance and cellular functions. In this state, cellular immunity, particularly T-cell mediated responses, is impaired, reducing the capacity to control viral spread and respond to new antigenic challenges such as those presented by vaccines [2, 10].

Moreover, the immune regulatory pathways become dysregulated. Studies in American mink have linked certain genomic regions, including candidate genes involved in immune responses, to differential outcomes following AMDV infection [22, 24]. While these genetic determinants are more directly associated with tolerance to the virus, they also indirectly influence the host’s overall immunological balance. In mink that have not been genetically screened or selected for tolerance, the rapid and chronic production of antibodies not only fails to clear the virus but further contributes to the immune suppression observed during chronic AMDV infection.

Another contributing factor is the virus’s ability to persist in lymphoid tissues. Persistent low-level viremia in organs, as detected by PCR even in animals with subclinical presentations, points to the virus’s capacity to evade clearance by the immune system [10]. This immune evasion ensures continuous antigenic stimulation and further exacerbates immune dysfunction, hindering the development of effective responses to both the virus and subsequently administered vaccines.

Predisposition to Secondary Infections

The state of immune suppression induced by chronic AMDV infection significantly increases the susceptibility of the mink to secondary infections. The compromised immune function, particularly the impaired deployment of effective cell-mediated responses, creates an open environment for opportunistic pathogens. In an immunosuppressed state, secondary bacterial infections become more common and can precipitate clinical disease that might otherwise have been a subclinical or self-limiting event if the immune system were functioning optimally [2].

In farm settings, this predisposition to secondary infections has critical economic and animal welfare implications. Bacterial infections that are secondary to chronic AMDV often exacerbate clinical signs, leading to higher rates of morbidity and mortality. Moreover, the inability to mount a robust response to standard vaccines may further complicate disease management, necessitating more stringent biosecurity and veterinary intervention protocols. Regulatory bodies such as the WOAH and FAO emphasize the importance of maintaining high immunocompetence in livestock populations, and the persistent immunosuppressive effects of AMDV undermine these recommendations, fostering an environment where both endemic and emerging infectious agents can thrive.

The interplay between vaccine inefficacy, immune suppression, and secondary infections is therefore a significant driver of the overall pathogenic burden associated with AMDV. Immune suppression can also lead to reduced clearance of co-infecting agents and prolonged infections, further straining the health of both individual animals and the herd. Such conditions underscore the need for integrated management strategies that take into account the complex immunopathogenesis of chronic AMDV infection. Advanced molecular diagnostics and genome-based selection strategies are being studied as potential avenues to mitigate these problems by identifying and breeding for more tolerant animals that demonstrate a more balanced immune profile [24].

Thus, a deep understanding of the mechanisms behind vaccine response alteration, immune suppression, and secondary infection susceptibility in chronic AMDV cases is essential. This knowledge guides both the development of novel therapeutic strategies, including potential antiviral interventions, and the implementation of effective biosecurity and vaccination programs consistent with guidelines from international health authorities such as the CDC and FAO.

Cross-Species Transmission and Spillover Dynamics Among Native Mustelids

The phenomenon of cross‐species transmission of Aleutian disease virus (AMDV) among native mustelids embodies a multifaceted interplay between viral evolution, host phylogenetic proximity, environmental interfaces, and anthropogenic pressures. Native mustelids, including species such as polecats, weasels, badgers, and martens, frequently share overlapping ecosystems with invasive American mink, facilitating the spillover of AMDV from a non‐native reservoir to indigenous species [27, 28]. The process is shaped by both biological mechanisms at the cellular level and broader epidemiological trends that determine viral persistence within multi‐host communities.

Biological Mechanisms Underpinning Spillover

At the cellular level, AMDV exhibits a remarkable ability to exploit host immune responses to persist and propagate in both farmed and wild populations. The virus targets key immune and hematopoietic cells, and it has been demonstrated that the chronic infection can lead to hypergammaglobulinemia and immune complex deposition. In native mustelids, the viral capacity for cross-species infection appears to be largely governed by receptor compatibility and the virus's high genetic variability; these factors permit replication in diverse immune environments that differ from the original mink host [27, 28]. The spillover dynamic is further modulated by structural adaptations in the viral capsid proteins, which not only determine antigenicity but also influence host range. Studies employing cryo-electron microscopy have elucidated variations in the surface loops of the capsid that may facilitate accommodation to different cellular receptors across mustelid species [9]. This molecular flexibility is one of the key determinants in the virus’s ability to cross natural species barriers.

The evolutionary pressures exerted by heterogeneous host immune systems likely drive the selection of viral variants with enhanced replication efficiency in native mustelids. Genetic sequencing data of AMDV isolates from free-ranging species indicate that while variants in farmed mink often adhere to a relatively narrow phylogenetic grouping, those circulating among native mustelids exhibit higher diversity and may include adaptations that favor transmission in wild populations [27, 28]. Inherent differences in immune response, as evidenced by disparities in seroprevalence and PCR positivity between closely related mustelid species, suggest that phylogenetically closer species such as polecats and weasels are more frequently and efficiently infected compared to more distantly related species like badgers [27]. This observation aligns with the concept of “phylogenetic host filtering,” wherein the virus preferentially establishes persistent infections in hosts that are immunologically and evolutionarily similar to its primary reservoir.

Epidemiological Patterns and Environmental Interfaces

From an epidemiological standpoint, the dynamics of AMDV transmission in native mustelids are driven by a complex ecological interface between invasive and indigenous species. Detailed seroprevalence studies conducted in Poland have shown that AMDV antibodies have been detected not only in American mink but also in all investigated native mustelid species, including previously unreported findings in weasels [27]. The seroprevalence reported in native mustelids approaches 68% in species that are closely related to the mink, suggesting that ecological overlap with farm escapees and feral populations may serve as significant conduits for viral introduction into native communities.

Regional studies over extended periods have demonstrated a dramatic increase in AMDV seroprevalence in native mustelids, climbing from marginal levels to over 60% in some areas [27]. This rise occurs even as viral prevalence in American mink fluctuates or declines, suggesting that once introduced into a native population, the virus achieves efficient intraspecific circulation. Environmental factors such as shared denning sites, communal foraging areas, and overlapping territories may potentiate direct contact or indirect transmission through environmental contamination. The presence of AMDV genetic material in both biological samples and environmental swabs from infected farms reinforces the role of fomite-mediated spread across species boundaries [4, 30]. Agencies such as the Centers for Disease Control and Prevention (CDC) and the World Organisation for Animal Health (WOAH) both underscore the importance of rigorous biosecurity measures to control pathogens capable of multi-species transmission, a recommendation that is particularly pertinent given the persistent environmental reservoirs of AMDV.

The anthropogenic impact cannot be understated; the introduction of invasive American mink for fur farming has not only disrupted native ecosystems but also inadvertently established a reservoir for AMDV spillover. The proximity of mink farms to natural habitats, combined with the frequent escape of farmed individuals into the wild, creates bridging events that facilitate transmission to resident mustelid populations [27, 28]. Compounding this issue is the failure of conventional diagnostic and management practices to fully contain the virus within captive settings, thereby prolonging its presence in the environment. This interplay between human-managed populations and native wildlife amplifies the risk of long-term ecological impacts, as confirmed by extensive epidemiological surveillance studies.

Viral Persistence and Host-Pathogen Coevolution

The persistent nature of AMDV in native mustelid populations is also linked to the host-pathogen coevolution occurring within these species. As AMDV establishes a chronic infection, native hosts may gradually develop a state of tolerance rather than true resistance, with immune responses that are less effective in clearing the virus yet sufficient to prevent acute disease manifestations [28]. This scenario creates an endemic state where the virus circulates continuously without inducing overt clinical outbreaks, thereby evading detection and control measures. Such dynamics complicate efforts to implement effective wildlife disease surveillance and management programs, as posited by global health organizations like the FAO, which emphasize the need for integrated approaches in managing pathogens with multi-host potential.

Comparative molecular analyses of AMDV strains isolated from both farmed and free-ranging mink reveal that while the virus maintains a common ancestral lineage, distinct genetic clusters emerge among native mustelids. These clusters, characterized by unique amino acid substitutions and non-synonymous mutations in critical regions such as VP2 and NS1, imply adaptive evolution in response to host-specific pressures [6, 27]. Over extended periods, the interplay between viral mutation and host immune selection pressures could lead to the emergence of novel viral strains that are even better adapted to native mustelids. This adaptive radiation complicates efforts to trace transmission pathways and underscores the need for whole-genome sequencing strategies to unravel the complex epidemiological networks at play [17, 20].

Anthropogenic and Ecological Implications

The cross-species transmission of AMDV among native mustelids highlights broader ecological and conservation issues. Recent studies have indicated that subclinical infections in native animals may have subtle yet significant impacts on fitness, reproduction, and population dynamics [27, 40]. Even in the absence of overt clinical disease, chronic viral infection can impair host vigor and reduce overall survival, thereby exerting a cumulative pressure on already vulnerable native populations. This scenario is of particular concern for the conservation of endangered mustelid species, where even marginal declines in fitness may contribute to population declines.

Furthermore, the ecological complexity is amplified by the potential for additional spillover events into non-mustelid species. Reports of AMDV antibodies and genetic material in other carnivoran species, such as foxes and badgers, hint at a broader host range that could facilitate widespread environmental dissemination [39, 40]. These multifaceted transmission networks reinforce the necessity for cross-sectoral surveillance initiatives that incorporate guidelines from international bodies such as the WHO and WOAH, ensuring that both animal health and ecosystem stability are maintained.

The persistent circulation of AMDV within native mustelid communities not only poses a significant challenge to wildlife management and conservation but also serves as a model for understanding the complexities of pathogen spillover in multi-host systems. The integration of molecular epidemiology with ecological and immunological studies forms a robust framework for delineating the factors that drive these cross-species transmission events and underscores the critical need for coordinated biosecurity measures at the wildlife–livestock interface.

References

[1] Vahedi SM, Ardestani SS, Banabazi MH, Clark FK. Epidemiology, pathogenesis, and diagnosis of Aleutian disease caused by Aleutian mink disease virus: A literature review with a perspective of genomic breeding for disease control in American mink (Neogale vison). Virus Research. 2023. DOI: https://doi.org/10.1016/j.virusres.2023.199208

[2] Żmuda A, Kostro K, Lisiecka U. Specific humoral immunity in mink infected with the Aleutian disease virus (AMDV) and vaccinated against distemper. Medycyna Weterynaryjna. 2021. DOI: https://doi.org/10.21521/MW.6544

[3] Kowalczyk M, Jakubczak A, Gryzińska M. Duplex PCR for Detection of Aleutian Disease Virus from Biological and Environmental Samples. Acta Veterinaria. 2019. DOI: https://doi.org/10.2478/acve-2019-0034

[4] Przywara K, Siemionek J, Jakubowski T, Kończyk-Kmiecik K, Szczerba-Turek A. Prevalence of Aleutian Mink Disease Virus (AMDV) in Free-Ranging American Mink from Biebrza and Narew National Parks (Poland), An Epidemiological Concern. Animals. 2024. DOI: https://doi.org/10.3390/ani14172584

[5] Jakubczak A, Kowalczyk M, Kostro K, Jeżewska-Witkowska G. Comparative molecular analysis of strains of the Aleutian Disease Virus isolated from farmed and wild mink.. Annals of Agricultural and Environmental Medicine. 2017. DOI: https://doi.org/10.26444/aaem/75688

[6] Cui X, Yang Y, Wang F, Luo J, Zhang P, Chen H, et al.. Genomic characterization and phylogenetic analysis of Aleutian mink disease virus identified in a sudden death mink case.. Comparative Immunology, Microbiology & Infectious Diseases. 2023. DOI: https://doi.org/10.1016/j.cimid.2023.102052

[7] Virtanen J, Aaltonen K, Moisander-Jylhä A, Nordgren H, Paulin L, Peura J, et al.. Mechanisms behind the varying severity of Aleutian mink disease virus: Comparison of three farms with a different disease status.. Veterinary Microbiology. 2022. DOI: https://doi.org/10.21203/rs.3.rs-1283464/v1

[8] Andersson A, Reineck HB, Nyman A, Wallgren P. Quantitative Detection of Antibodies to Aleutian Disease Virus in DriedBlood Spots as an Estimation of Hypergammaglobulinemia in Mink. Virology & Mycology. 2015. DOI: https://doi.org/10.4172/2161-0517.1000147

[9] Lakshmanan R, Mietzsch M, Ybargollin AJ, Chipman P, Fu X, Qiu J, et al.. Capsid Structure of Aleutian Mink Disease Virus and Human Parvovirus 4: New Faces in the Parvovirus Family Portrait. Viruses. 2022. DOI: https://doi.org/10.3390/v14102219

[10] Farid A, Hussain I, Rupasinghe P, Stephen J, Arju I. Long-term antibody production and viremia in American mink (Neovison vison) challenged with Aleutian mink disease virus. BMC Veterinary Research. 2022. DOI: https://doi.org/10.1186/s12917-022-03462-7

[11] Virtanen J, Smura T, Aaltonen K, Moisander-Jylhä A, Knuuttila A, Vapalahti O, et al.. Co-circulation of highly diverse Aleutian mink disease virus strains in Finland.. Journal of General Virology. 2019. DOI: https://doi.org/10.1099/jgv.0.001187

[12] Franzo G, Legnardi M, Grassi L, Dotto G, Drigo M, Cecchinato M, et al.. Impact of viral features, host jumps and phylogeography on the rapid evolution of Aleutian mink disease virus (AMDV). Scientific Reports. 2021. DOI: https://doi.org/10.1038/s41598-021-96025-z

[13] Prieto A, Fernández-Antonio R, López-Lorenzo G, Díaz-Cao JM, López-Novo C, Remesar S, et al.. Molecular epidemiology of Aleutian mink disease virus causing outbreaks in mink farms from Southwestern Europe: a retrospective study from 2012 to 2019. Journal of Veterinary Sciences. 2020. DOI: https://doi.org/10.4142/jvs.2020.21.e65

[14] Farid A, Ferns LE. Reduced severity of histopathological lesions in mink selected for tolerance to Aleutian mink disease virus infection.. Research in Veterinary Science. 2017. DOI: https://doi.org/10.1016/j.rvsc.2017.02.009

[15] Kowalczyk M, Horecka B, Jakubczak A. Aleutian Mink Disease Virus in the breeding environment in Poland and its place in the global epidemiology of AMDV.. Virus Research. 2019. DOI: https://doi.org/10.1016/j.virusres.2019.197665

[16] Ryt-Hansen P, Hjulsager C, Hagberg E, Chriel M, Struve T, Pedersen AG, et al.. Outbreak tracking of Aleutian mink disease virus (AMDV) using partial NS1 gene sequencing. Virology Journal. 2017. DOI: https://doi.org/10.1186/s12985-017-0786-5

[17] Hagberg E, Pedersen A, Larsen L, Krarup A. Evolutionary analysis of whole-genome sequences confirms inter-farm transmission of Aleutian mink disease virus.. Journal of General Virology. 2017. DOI: https://doi.org/10.1099/jgv.0.000777

[18] Nituch L, Bowman J, Wilson P, Schulte‐Hostedde A. Molecular epidemiology of Aleutian disease virus in free-ranging domestic, hybrid, and wild mink. Evolutionary Applications. 2012. DOI: https://doi.org/10.1111/j.1752-4571.2011.00224.x

[19] Farid A, Rupasinghe P. Accuracy of enzyme-linked immunosorbent assays for quantification of antibodies against Aleutian mink disease virus.. Journal of Virological Methods. 2016. DOI: https://doi.org/10.1016/j.jviromet.2016.06.004

[20] Hagberg E, Krarup A, Fahnøe U, Larsen L, Dam-Tuxen R, Pedersen A. A fast and robust method for whole genome sequencing of the Aleutian Mink Disease Virus (AMDV) genome.. Journal of Virological Methods. 2016. DOI: https://doi.org/10.1016/j.jviromet.2016.03.010

[21] Jensen TH, Uttenthal A. Aleutian mink disease virus. CABI Compendium. 2016. DOI: https://doi.org/10.1201/B19719-80

[22] Mazurkiewicz I, Jakubczak A, Kowalczyk M. Polymorphism of the RNF165 Gene in American Mink (Neogale vison) as a Potential Factor Responsible for Resistance to Infection with the Aleutian Mink Disease Virus. Genes. 2025. DOI: https://doi.org/10.3390/genes16121417

[23] Karimi K, Farid A, Myles S, Miar Y. Detection of selection signatures for response to Aleutian mink disease virus infection in American mink. Scientific Reports. 2021. DOI: https://doi.org/10.1038/s41598-021-82522-8

[24] Vahedi SM, Ardestani SS, Banabazi MH, Clark K. Strong selection signatures for Aleutian disease tolerance acting on novel candidate genes linked to immune and cellular responses in American mink (Neogale vison). Scientific Reports. 2024. DOI: https://doi.org/10.1038/s41598-023-51039-7

[25] Lu T, Zhang H, Zhou J, Ma Q, Yan W, Zhao L, et al.. Aptamer-targeting of Aleutian mink disease virus (AMDV) can be an effective strategy to inhibit virus replication. Scientific Reports. 2021. DOI: https://doi.org/10.1038/s41598-021-84223-8

[26] Farid A, Hussain I. A comparison between intraperitoneal injection and intranasal and oral inoculation of mink with Aleutian mink disease virus.. Research in Veterinary Science. 2019. DOI: https://doi.org/10.1016/j.rvsc.2019.02.006

[27] Zalewski A, Kołodziej-Sobocińska M, Virtanen J, Zalewska H, Sironen T, Zub K, et al.. Drivers Shaping Spillover of Aleutian Mink Disease Virus Introduced With American Mink Among Native Mustelids. Transboundary and Emerging Diseases. 2025. DOI: https://doi.org/10.1155/tbed/3184679

[28] Virtanen J, Zalewski A, Kołodziej-Sobocińska M, Brzeziński M, Smura T, Sironen T. Diversity and transmission of Aleutian mink disease virus in feral and farmed American mink and native mustelids. Virus Evolution. 2021. DOI: https://doi.org/10.1093/ve/veab075

[29] Panicz R, Eljasik P, Skorupski J, Śmietana P, Stefánsson RA, Schmalensee Mv, et al.. Assessment of Aleutian mink disease virus (AMDV) prevalence in feral American mink in Iceland. Case study of a pending epizootiological concern in Europe. PeerJ. 2021. DOI: https://doi.org/10.7717/peerj.12060

[30] Prieto A, Díaz-Cao JM, Fernández-Antonio R, Panadero R, López-Lorenzo G, Díaz P, et al.. Lesser housefly (Fannia canicularis) as possible mechanical vector for Aleutian mink disease virus.. Veterinary Microbiology. 2018. DOI: https://doi.org/10.1016/j.vetmic.2018.05.024

[31] Cao JMD, Prieto A, López G, Fernández-Antonio R, Díaz P, López C, et al.. Molecular assessment of visitor personal protective equipment contamination with the Aleutian mink disease virus and porcine circovirus-2 in mink and porcine farms. PLoS ONE. 2018. DOI: https://doi.org/10.1371/journal.pone.0203144

[32] Persson S, Jensen TH, Blomström A, Appelberg MT, Magnusson U. Aleutian Mink Disease Virus in Free-Ranging Mink from Sweden. PLoS ONE. 2015. DOI: https://doi.org/10.1371/journal.pone.0122194

[33] Virtanen J, Aaltonen K, Vapalahti O, Sironen T. Development and validation of nucleic acid tests to diagnose Aleutian mink disease virus.. Journal of Virological Methods. 2019. DOI: https://doi.org/10.1016/j.jviromet.2019.113776

[34] Li L, Hu Z, Sun J, Guo K, Chu X, Wang X, et al.. Development of an EvaGreen-based real-time PCR assay for detection of Aleutian mink disease virus.. Journal of Virological Methods. 2019. DOI: https://doi.org/10.1016/j.jviromet.2019.113751

[35] Farid A, Rupasinghe P. A fast and accurate method of detecting Aleutian mink disease virus in blood and tissues of chronically infected mink.. Canadian Journal of Microbiology (print). 2017. DOI: https://doi.org/10.1139/cjm-2016-0567

[36] Hu G, Do D, Davoudi P, Manafiazar G, Kelvin A, Plastow G, et al.. Genetic and Phenotypic Correlations between Aleutian Disease Tests with Body Weight, Growth, and Feed Efficiency Traits in Mink.. Journal of Animal Science. 2022. DOI: https://doi.org/10.1093/jas/skac346

[37] Kowalczyk M, Gąsiorek B, Kostro K, Borzym E, Jakubczak A. Breeding parameters on a mink farm infected with Aleutian mink disease virus following the use of methisoprinol. Archives of Virology. 2019. DOI: https://doi.org/10.1007/s00705-019-04375-x

[38] Jensen TH, Chriel M, Hansen MS. Progression of experimental chronic Aleutian mink disease virus infection. Acta Veterinaria Scandinavica. 2015. DOI: https://doi.org/10.1186/s13028-016-0214-7

[39] Høeg FJ, Hammer AS, Eiersted ACB, Verhoeven JTP, Larsen LE, Jensen TK, et al.. A Novel Amdoparvovirus of Badgers and Foxes and the Perpetuation of Aleutian Mink Disease Virus 3 in the Wildlife of Denmark. Pathogens. 2025. DOI: https://doi.org/10.3390/pathogens14080734

[40] Załęska-Wawro M, Szczerba-Turek A, Szweda W, Siemionek J. Seroprevalence and Molecular Epidemiology of Aleutian Disease in Various Countries during 1972–2021: A Review and Meta-Analysis. Animals. 2021. DOI: https://doi.org/10.3390/ani11102975